Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Abstract Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics. Here, we have used 1062 EA patients with two years of follow-up to explore the value of anti-carbamylated protei...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cristina Regueiro, Laura Nuño, Ana M. Ortiz, Diana Peiteado, Alejandro Villalba, Dora Pascual-Salcedo, Ana Martínez-Feito, Isidoro González-Alvaro, Alejandro Balsa, Antonio González
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/fc886adb586649bfb6a85851118c4f73
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares